Edition:
United Kingdom

Shire PLC (SHP.L)

SHP.L on London Stock Exchange

4,690.00GBp
7 Jan 2019
Change (% chg)

0.00 (+0.00%)
Prev Close
4,690.00
Open
4,690.00
Day's High
4,690.00
Day's Low
4,690.00
Volume
0
Avg. Vol
4,532,743
52-wk High
4,827.75
52-wk Low
2,940.50

Latest Key Developments (Source: Significant Developments)

Shire Says Following Court Order, Scheme Has Now Become Effective
Tuesday, 8 Jan 2019 

Jan 8 (Reuters) - Shire Plc::SHIRE PLC - FOLLOWING COURT ORDER , SCHEME HAS NOW BECOME EFFECTIVE, ENTIRE ISSUED AND TO BE ISSUED SHARE CAPITAL OF SHIRE IS NOW OWNED BY TAKEDA.  Full Article

Takeda - Notice Regarding Amounts Of Capital And Capital Reserves To Be Increased By Issuance Of New Shares In Connection With Shire Acquisition
Tuesday, 8 Jan 2019 

Jan 8 (Reuters) - Takeda Pharmaceutical Co Ltd <4502.T>::NOTICE REGARDING AMOUNTS OF CAPITAL AND CAPITAL RESERVES TO BE INCREASED BY ISSUANCE OF NEW SHARES IN CONNECTION WITH SHIRE ACQUISITION.AMOUNTS OF BOTH STATED CAPITAL AND CAPITAL RESERVES TO BE INCREASED BY ABOUT 1.565 TRLN YEN EACH.  Full Article

Takeda Says It Now Owns Entire Issued And To Be Issued Share Capital Of Shire
Tuesday, 8 Jan 2019 

Jan 8 (Reuters) - Japan's Takeda Pharmaceutical Co Ltd <4502.T>::NOTICE REGARDING THE ACQUISITION OF THE ENTIRE ISSUED AND TO BE ISSUED SHARE OF SHIRE.CONFIRMS SCHEME OF ARRANGEMENT IN RELATION TO PROPOSED ACQUISITION OF SHIRE BECAME EFFECTIVE JAN 8.ENTIRE ISSUED AND TO BE ISSUED SHARE CAPITAL OF SHIRE IS NOW OWNED BY TAKEDA.  Full Article

Shire Plc Says Thomas Dittrich, Chief Financial Officer And Executive Director, Has Resigned
Tuesday, 8 Jan 2019 

Jan 7 (Reuters) - Shire Plc ::SAYS THOMAS DITTRICH, CHIEF FINANCIAL OFFICER AND EXECUTIVE DIRECTOR, HAS RESIGNED.ANNOUNCES THAT DIRECTORS OF SHIRE HAVE TENDERED THEIR RESIGNATIONS.SHIRE-FLEMMING ORNSKOV WILL BE RETAINED BY SHIRE AS EMPLOYEE TO ACT IN AN ADVISORY CAPACITY TO CEO OF TAKEDA FOR THREE MONTHS ENDING ON MARCH 31, 2019.FLEMMING ORNSKOV, CHIEF EXECUTIVE OFFICER AND EXECUTIVE DIRECTOR, HAS RESIGNED.SHIRE - THOMAS DITTRICH WILL BE RETAINED BY SHIRE AS AN EMPLOYEE TO ACT IN ADVISORY CAPACITY TO CHIEF FINANCIAL OFFICER OF TAKEDA UNTIL MARCH 3, 2019.TAKEDA HAS APPOINTED OLIVIER BOHUON, IAN CLARK AND STEVEN GILLIS TO THE TAKEDA BOARD EFFECTIVE AS OF TODAY’S DATE.AMONG DIRECTORS OF SHIRE TO HAVE TENDERED RESIGNATION IS SUSAN KILSBY, NON-EXECUTIVE DIRECTOR AND CHAIRMAN.  Full Article

Takeda CEO Says Selling Consumer Business Is Not Our First Priority In Terms Of Accelerating Deleverage
Monday, 7 Jan 2019 

Jan 7 (Reuters) - Takeda <4502.T>::CEO SAYS SELLING CONSUMER BUSINESS IS NOT OUR FIRST PRIORITY IN TERMS OF ACCELERATING DELEVERAGE.  Full Article

Mylan Announces U.S. Launch Of Mesalamine Delayed-Release Tablets USP, 1.2 g
Monday, 17 Dec 2018 

Dec 17 (Reuters) - Mylan NV ::LAUNCH OF GENERIC LIALDA® DELAYED-RELEASE TABLETS EXPANDS MYLAN'S GASTROENTEROLOGY PRODUCT OFFERING.MYLAN NV - ANNOUNCED U.S. LAUNCH OF MESALAMINE DELAYED-RELEASE TABLETS USP, 1.2 G, A GENERIC VERSION OF SHIRE'S LIALDA DELAYED-RELEASE TABLETS.  Full Article

Takeda Reaffirms Strategic & Financial Rationale For Shire Acquisition
Monday, 12 Nov 2018 

Nov 12 (Reuters) - Takeda Pharmaceutical Co Ltd <4502.T>::ANNOUNCES PUBLICATION OF CIRCULAR AND NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS IN RELATION TO PROPOSED ACQUISITION OF SHIRE.REAFFIRMS STRATEGIC AND FINANCIAL RATIONALE FOR SHIRE ACQUISITION.  Full Article

Takeda Says To Hold Extraordinary Shareholders Meeting Dec 5 To Vote On Matters Related To Shire Acquisition
Monday, 12 Nov 2018 

Nov 12 (Reuters) - Takeda Pharmaceutical Co Ltd <4502.T>::TAKEDA SAYS TO HOLD EXTRAORDINARY SHAREHOLDERS MEETING DEC 5 TO VOTE ON MATTERS RELATED TO SHIRE ACQUISITION.  Full Article

Takeda Announces Issuance Of Unsecured Euro Denominated Senior Notes
Thursday, 8 Nov 2018 

Nov 8 (Reuters) - Takeda Pharmaceutical Co Ltd <4502.T>::TAKEDA ANNOUNCES ISSUANCE OF UNSECURED EURO DENOMINATED SENIOR NOTES.  Full Article

Shire Q3 Revenue Rises 5 Pct To $3.87 Bln, Takeda Deal On Track To Close In H1 2019
Thursday, 1 Nov 2018 

Nov 1 (Reuters) - Shire PLC ::SHIRE PLC - PRODUCT SALES GROWTH OF 6% AND CONTINUES TO EXECUTE AGAINST KEY PRIORITIES IN Q3 2018.SHIRE PLC - TAKEDA'S PROPOSED ACQUISITION OF SHIRE REMAINS ON TRACK TO CLOSE IN H1 2019.SHIRE PLC - Q3 TOTAL REVENUES OF $3,872 MILLION REPRESENTING GROWTH OF 5%.SHIRE PLC - Q3 OPERATING INCOME INCREASED 35% TO $956 MILLION.SHIRE PLC - QTRLY DILUTED EARNINGS PER ADS $1.75.SHIRE PLC - QTRLY NON GAAP DILUTED EARNINGS PER ADS $3.64.SHIRE PLC - Q3 NON GAAP EBITDA MARGIN WAS SLIGHTLY DOWN TO 42% (Q3 2017: 44%).SHIRE PLC - CONTINUE TO EXPECT TO ACHIEVE MID-FORTIES NON GAAP EBITDA MARGIN BY 2020.SHIRE PLC - PROJECTED 2020 REVENUE TARGET UPDATED TO $16.5 - $17.5 BILLION, REFLECTING REMOVAL OF $0.5 BILLION OF ONCOLOGY SALES IN ORIGINAL PROJECTION.SHIRE PLC - SEES FY TOTAL REVENUE $15.3 - $15.8 BILLION.SHIRE PLC - SEES FY DILUTED EARNINGS PER ADS $7.17 - $7.77.SHIRE PLC - SEES FY NON GAAP DILUTED EARNINGS PER ADS $14.77 - $15.37.  Full Article

Nikkei tracks sharp Wall Street gains; machinery, exporters attract gains

TOKYO, Jan 7 Japan's Nikkei rose on Monday, tracking sharp gains on Wall Street as dovish comments from the Federal Reserve chairman helped ease some of the market's worries about a slowdown in global growth.